Eli Lilly Total Liabilities 2010-2024 | LLY

Eli Lilly total liabilities for the quarter ending September 30, 2024 were $61.286B, a 31.49% increase year-over-year.

  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.
  • Eli Lilly total liabilities for 2022 were $38.714B, a 2.36% decline from 2021.
  • Eli Lilly total liabilities for 2021 were $39.651B, a 2.83% decline from 2020.

Eli Lilly Total Liabilities 2010-2024 | LLY

  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.
  • Eli Lilly total liabilities for 2022 were $38.714B, a 2.36% decline from 2021.
  • Eli Lilly total liabilities for 2021 were $39.651B, a 2.83% decline from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$472.8B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$355.5B
Merck (MRK)$255.1B
Novartis AG (NVS)$218.3B
AstraZeneca (AZN)$198B
Pfizer (PFE)$155B
Sanofi (SNY)$130.1B
Innoviva (INVA)$1.2B